Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety
2 other identifiers
interventional
23,026
1 country
1
Brief Summary
This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate partner violence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Jun 2019
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2020
CompletedFirst Submitted
Initial submission to the registry
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
November 5, 2021
CompletedResults Posted
Study results publicly available
April 5, 2022
CompletedApril 13, 2023
February 1, 2022
8 months
October 26, 2021
December 23, 2021
March 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Pre mPATH Use
The primary outcome will be the proportion of patients seen in each time period ("pre" vs. "post") who screen positive for depression, fall risk, or intimate partner violence. The "pre" time period will be Days -60 to -1 (the 60 day period before mPATH Launch). Screening positive for depression will be a score of 3 or greater on the Patient Health Questionnaire-2. Screening positive for fall risk will be answering "yes" to having a device to assist with mobility and/or having fallen in the last year. Screening positive for intimate partner violence will be answering yes to any of the health system's three questions about safety in the home.
2 months prior to use of intervention
Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Post mPATH Use
The primary outcome will be the proportion of patients seen in each time period ("pre" vs. "post") who screen positive for depression, fall risk, or intimate partner violence. The "post" time period will be days 14 to 73 (the 60 day period commencing 2 weeks after mPATH Launch). Screening positive for depression will be a score of 3 or greater on the Patient Health Questionnaire-2. Screening positive for fall risk will be answering "yes" to having a device to assist with mobility and/or having fallen in the last year. Screening positive for intimate partner violence will be answering yes to any of the health system's three questions about safety in the home.
2 months after use of intervention
Secondary Outcomes (7)
Number of Participants Screening Positive for Depression Using Patient Health Questionnaires (PHQ-2 Score of 3 or Greater)
2 months before and 2 months after using intervention
Number of Participants Screening Positive for Moderately Severe or Severe Depression Using Patient Health Questionnaires (PHQ-9 Score Greater Than 14)
2 months before and 2 months after using intervention
Number of Participants Screening Positive for Severe Depression Using Patient Health Questionnaires (PHQ-9 Score Greater Than 19)
2 months before and 2 months after using intervention
Number of Participants With a Patient Health Questionnaires (PHQ-9 Score Greater Than 14) and Not Currently Taking a Medication for Depression.
2 months before and 2 months after using intervention
Number of Participants Who Report Thoughts of Self Harm - Patient Health Questionnaire (PHQ-9) in All Practices
2 months before and 2 months after using intervention
- +2 more secondary outcomes
Study Arms (1)
Primary Care Office Visits
OTHERThe limited use dataset will contain the following data elements for each completed patient visit: * Date of clinic visit (where each date is indicated by a number relative to the clinic's Launch Date) * Clinic (designated by a unique study clinic identifier) * Type of visit completed (for example, new patient visit, return patient visit, annual exam) * Patient age * Patient gender * Patient race/ethnicity * Patient primary insurance * Nursing staff who roomed the patient (designated by a unique study identifier) * Whether patient used mPATH-CheckIn program (Y/N) * Whether nursing staff used mPATH Nursing Module to transmit mPATH data to electronic health record (Y/N) * Whether patient has a diagnosis of depression in the problem list in the EHR (Y/N) * Whether patient has an antidepressant medication listed in the active medication list ( (Y/N) * Results of depression screening items * Results of fall risk screening items * Results of safety at home screening items
Interventions
mPATH iPad program that contains self-administered screening items for depression, fall risk, and intimate partner violence
Eligibility Criteria
You may qualify if:
- Age 18 or older
- Completed a provider visit at the study clinic during the 60 days prior to the clinic launching the mPATH program (the "pre" time period), or completed a provider visit at the study clinic during days 14 - 73 after the launch of mPATH (the "post" time period)
- Have a preferred language of English or Spanish
You may not qualify if:
- Requiring a language interpreter for a language other than Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Study Coordinator
- Organization
- Wake Forest Baptist Health Sciences
Study Officials
- PRINCIPAL INVESTIGATOR
David Miller, MD, MS
Wake Forest Baptist Health Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2021
First Posted
November 5, 2021
Study Start
June 24, 2019
Primary Completion
February 27, 2020
Study Completion
February 27, 2020
Last Updated
April 13, 2023
Results First Posted
April 5, 2022
Record last verified: 2022-02